Patient With Neuropathic Pain
Conditions
Keywords
Neuropathic pain, magnesium
Brief summary
Use lay language. The aim of this study is to evaluate on pain scores (neuropathic pain questionnaire and pain numeric scale) and on quality of life, the effect of oral magnesium intake on patients with neuropathic pain comparing with patients receiving placebo,. The study drug will be taken during 4 weeks.
Detailed description
Protocol description Visit D0 * patient inclusion after informed signed consent * clinical exam * blood sampling (magnesium dosage) * questionnaires (neuropathic pain and quality of life) * daily self-evaluation on neuropathic pain scale (Week0 to Week5) D8 : first intake of study drug (magnesium or placebo) Visit Week5: * questionnaires (neuropathic pain and quality of life) * blood sampling (magnesium dosage) * clinical exam
Interventions
DRUGMagnogene ® (magnesium)
evaluate on pain scores (neuropathic pain questionnaire and pain numeric scale) and on quality of life, the effect of oral magnesium intake on patients with neuropathic pain comparing with patients receiving placebo,. The study drug will be taken during 4 weeks.
Sponsors
University Hospital, Clermont-Ferrand
Study design
Allocation
RANDOMIZED
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
\- neuropathic pain \- informed signed consent
Exclusion criteria
* magnesium intake contra-indication * severe renal insufficiency * quinidine intake * concomitant treatment change 2weeks before inclusion * evolutive pathology
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain scores (neuropathic pain evaluation questionnaire) | Visit D0 |
Secondary
| Measure | Time frame |
|---|---|
| - Numeric scale - quality o f life questionnaires | Visit Week 5 |
Countries
France
Outcome results
None listed